4.7 Article

Insight into the binding mode of HIF-2 agonists through molecular dynamic simulations and biological validation

期刊

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2020.112999

关键词

HIF-2; Agonist; Binding mode; Molecular dynamic simulations

资金

  1. National Natural Science Foundation of China [81773571]
  2. Jiangsu Province Funds for Excellent Young Scientists [BK20170088]

向作者/读者索取更多资源

This study involves the identification and evaluation of HIF-2 agonists, M1001 and its analog M1002, highlighting their potential as novel therapeutic agents for human oxygen metabolism. The use of molecular dynamics simulations allowed for the proposal of a plausible binding mode for these agonists, complemented by the synthesis and evaluation of compounds to verify the proposed mode. Compound 10 demonstrated improved agonistic activity and reduced toxicity compared to M1002, indicating its potential for further development.
Hypoxia-inducible factor-2 (HIF-2), a heterodimeric transcriptional protein consisting of HIF-2 alpha and aryl hydrocarbon receptor nuclear translocator (ARNT) subunits, has a broad transcriptional profile that plays a vital role in human oxygen metabolism. M1001, a HIF-2 agonist identified by high-throughput screening (HTS), is capable of altering the conformation of Tyr281 of the HIF-2 alpha PAS-B domain and enhancing the affinity of HIF-2 alpha and ARNT for transcriptional activation. M1002, an analog of M1001, shows improved efficacy than M1001. However, the cocrystal structure of M1001 and HIF-2 has some defects in revealing the agonist binding mode due to the relatively low resolution, while the binding mode of M1002 remained unexplored. To in-depth understand agonist binding profiles, herein, the molecular dynamic (MD) simulations was applied to construct a stable agonist-protein model, and a possible binding mode was proposed through the analysis of the binding free energy and hydrogen bonding of the simulation results. Nine compounds were then synthesized and evaluated to verify the proposed binding mode. Among them, compound 10 manifested improved agonistic activity and reduced toxicity compared to M1002. This study provides deep insight into the binding mode of such HIF-2 agonists, which would be useful for designing novel agonists for HIF-2. (C) 2020 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据